Salvinorin A - From natural product to human therapeutics

被引:61
作者
Vortherms, Timothy A.
Roth, Bryan L. [1 ]
机构
[1] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA
[3] NIMH, Psychoact Drug Screening Program, Chapel Hill, NC 27599 USA
关键词
D O I
10.1124/mi.6.5.7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hallucinogenic plant Salvia divinorum, a member of the mint family, has traditionally been used by the Mazatec natives of southern Mexico to induce ritual visions and is increasingly used in the US for recreational purposes. The main active ingredient in the plant is the diterpene salvinorin A, which is structurally distinct from other chemical classes of hallucinogens. In recent high-throughput screening experiments, salvinorin A was found to bind to the kappa-opioid receptor (KOR) with high specificity. Chemical analogs of the compound are now under study, in concert with functional characterization of KOR, to determine whether modulation of KOR activity could provide a basis for new psychotropic: medications. Indeed, there are indications that salvinorin A or its congeners may prove useful in both psychiatric and non-psychiatric diseases.
引用
收藏
页码:257 / +
页数:10
相关论文
共 52 条
[21]   Synthetic studies of neoclerodane diterpenes from Salvia divinorum:: Selective modification of the furan ring [J].
Harding, Wayne W. ;
Schmidt, Matthew ;
Tidgewell, Kevin ;
Kannan, Pavitra ;
Holden, Kenneth G. ;
Dersch, Christina M. ;
Rothman, Richard B. ;
Prisinzano, Thomas E. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (12) :3170-3174
[22]   Neoclerodane diterpenes as a novel scaffold for μ opioid receptor ligands [J].
Harding, WW ;
Tidgewell, K ;
Byrd, N ;
Cobb, H ;
Dersch, CM ;
Butelman, ER ;
Rothman, RB ;
Prisinzano, TE .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (15) :4765-4771
[23]   Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum [J].
Harding, WW ;
Tidgewell, K ;
Schmidt, M ;
Shah, K ;
Dersch, CM ;
Snyder, J ;
Parrish, D ;
Deschamps, JR ;
Rothman, RB ;
Prisinzano, TE .
ORGANIC LETTERS, 2005, 7 (14) :3017-3020
[24]   Synthetic studies of neoclerodane diterpenes from Salvia divinorum:: Semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A [J].
Harding, WW ;
Schmidt, M ;
Tidgewell, K ;
Kannan, P ;
Holden, KG ;
Gilmour, B ;
Navarro, H ;
Rothman, RB ;
Prisinzano, TE .
JOURNAL OF NATURAL PRODUCTS, 2006, 69 (01) :107-112
[25]   Possible pharmacotherapy of the opioid κ receptor agonist for drug dependence [J].
Hasebe, K ;
Kawai, K ;
Suzuki, T ;
Kawamura, K ;
Tanaka, T ;
Narita, M ;
Nagase, H ;
Suzuki, T .
CURRENT STATUS OF DRUG DEPENDENCE / ABUSE STUDIES: CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY, 2004, 1025 :404-413
[26]  
JOHN TF, 2006, EUR J PHARMACOL, V4, P4
[27]   A unique binding epitope for salvinorin A, a non-nitrogenous kappa opioid receptor agonist [J].
Kane, BE ;
Nieto, MJ ;
McCurdy, CR ;
Ferguson, DM .
FEBS JOURNAL, 2006, 273 (09) :1966-1974
[28]   New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human κ opioid receptors [J].
Lee, DYW ;
Ma, ZZ ;
Liu-Chen, LY ;
Wang, YL ;
Chen, Y ;
Carlezon, WA ;
Cohen, B .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (19) :5635-5639
[29]   Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues [J].
Lee, DYW ;
Karnati, VVR ;
He, MS ;
Liu-Chen, LY ;
Kondaveti, L ;
Ma, ZZ ;
Wang, YL ;
Chen, Y ;
Beguin, C ;
Carlezon, WA ;
Cohen, B .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (16) :3744-3747
[30]  
Lee JY, 2005, TAPPI J, V4, P15